liege Market Share Analysis for November 2025

une ville, un esprit

Law and Government > Government

Domainliege.be

Year Founded--

Employees1001 - 5000

Annual Revenue$100M - $200M

liege

liege (including company regionals)

liege.be

See more website traffic and engagement information

liege Revenue up to November 2025 is 100M - 200M

revenue generated by liege top domains

liege top domains revenue over 3 years

Revenue for liege top domains

liege.be100M - 200M

See more with Sales Intelligence

Total visits to liege's top domains

Understand liege market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

liege.be185.2K

See more with Sales Intelligence

Avg. visit duration in liege's top domains

Analyze liege engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

liege.be00:01:20

See more with Sales Intelligence

Avg. pageviews on liege's top domains

See how liege keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

liege.be2.80

See more with Sales Intelligence

liege top competitors by domain

Top similar sites in November 2025, ranked by their affinity

wallonie.beCompany NameService public de Wallonie - ÉnergieEmployees201 - 500HQBelgium, FroidchapelleAnnual revenue$100M - $200MTotal visits1.2MLaw and Government > Government

Top technologies used by liege

These are the website technologies, by industry, used by liege top domains

Social (9)

Google+ Platform

Content Management System (4)

WordPress

Advertising (3)

DoubleClick

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from liege

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLiege partners with PDC*line Pharma SA.Liège, Belgium and Grenoble, France, December 6, 2023 - PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the completion of enrolment of the fourth cohort of patients in its PDC-LUNG-101 phase I/II clinical trial (NCT03970746) with PDC*lung01, the company's therapeutic cancer vaccine candidate for Non-Small Cell Lung Cancer (NSCLC).

NewsMerieux Partners invests into Liege $5.3M.Liege, Belgium, November 7, 2023 -Amyl Therapeutics, a preclinical stage biotechnology company developing an amyloid specific technology platform to treat diseases linked to amyloid fibrils, today announces the securing of €5M ($5.3M) additional funding from long-term investors Merieux Equity Partners and Noshaq, together with Mr Evren Ucok as a new investor.

NewsLiege launches fifteenth edition of the Prix de la Création liégeoise dans le domaine des arts plastiques.The City of Liège is launching the fifteenth edition of the "Prix de la Création liégeoise dans le domaine des arts plastiques".